Month: December 2022
The FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee meets on Sept. 27 in open session to discuss and make recommendations on a biologics license application from BrainStorm Therapeutics, Inc.…
The FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee meets on Sept. 27 in open session to discuss and make recommendations on a biologics license application from BrainStorm Therapeutics, Inc.…